MedPath

Blood Loss Reduction: Effect of Tranexamic Acid Routes in Different Knee Prosthesis: A Randomized Controlled Trial.

Phase 3
Completed
Conditions
Patients with primary osteoarthritis knee scheduled for unilateral primary total knee arthroplasty (TKA)
Primary TKA&#44
open&#45
box knee prosthesis&#44
closed&#45
Tranexamic acid
Registration Number
TCTR20170618001
Lead Sponsor
aresuan university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
228
Inclusion Criteria

All patients with the diagnosis of primary osteoarthritis knee scheduled for unilateral primary total knee arthroplasty (TKA) in Naresuan university hospital were enrolled.

Exclusion Criteria

Patients with preop hemoglobin level less than 10g/dL, previous history of thromboembolic event, renal insufficiency, cardiovascular disease or cerebrovascular accident were excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood loss 6,12,24,48,72,96 hr postop Perioperative blood loss, drainage blood loss, postop hemoglobin level
Secondary Outcome Measures
NameTimeMethod
pain score 6,12,24,48,72,96 hr postop visual analogue scale,knee flexion, Straight leg raising, extension lag 6,12,24,48,72,96 hr postop goniometer
© Copyright 2025. All Rights Reserved by MedPath